Meipu Medical (301033.SZ) granted 94,000 restricted stocks to 3 incentive objects.

Meipu Medical (301033.SZ) announced that the board of directors of the company believes that the Guangzhou Meipu Regenerative Medical Technology Co., Ltd.'s equity transfer plan to Xu Wei is in line with the company's long-term development strategy.

Zhitong FinanceJun 27 07:16 ET

Meipu Medical (301033.SZ) is planning to distribute 4 yuan for every 10 shares on June 26th after ex-right and ex-dividend.

Map Medical (301033.SZ) announced that the company's annual equity distribution plan for 2023: cash dividend of 10 shares...

Zhitong FinanceJun 19 05:49 ET

The general manager of Maipu Medical (301033.SZ) completed an increase of 7,600 shares

Maipu Medical (301033.SZ) issued an announcement. As of the disclosure date of this announcement, Wang Jianhua, the company's director and general manager, has...

Zhitong FinanceMay 31 06:39 ET

Maipu Medical (301033.SZ) was granted a cumulative increase of 5,200 shares by Director and General Manager Wang Jianhua

Zhitong Finance App News, Maipu Medical (301033.SZ) announced that Wang Jianhua, the company's director and general manager, has already passed halfway through the plan to increase his holdings. Wang Jianhua has increased his holdings by 5,200 shares, accounting for 0.0079% of the company's total share capital. The increase amount is 152,800 yuan (not including transaction fees).

Zhitong FinanceMay 6 07:44 ET

Maipu Medical (301033.SZ) announced first-quarter results, net profit of 149.44,800 yuan, an increase of 91.19% year-on-year

Maipu Medical (301033.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved an operating income of 5...

Zhitong FinanceApr 24 04:24 ET

Maipu Medical (301033.SZ): Achieving revenue of 231 million yuan in 2023, plans to distribute 10 to 4 yuan

Gelonghui, April 18 | Maipu Medical (301033.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 231 million yuan, an increase of 18.24%; net profit attributable to shareholders of listed companies was 408.774 million yuan, up 13.89% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 37.233 million yuan, an increase of 55.54% year on year; basic earnings per share of 0.62 yuan; it plans to distribute a cash dividend of 4.00 yuan (tax included) to all shareholders for every 10 shares.

Gelonghui FinanceApr 18 07:11 ET